Marpai, Inc., a Delaware-based healthcare technology company, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 30, 2024, for a Form S-1 registration. The company, which operates under the ticker symbol MRAI on the OTCQX Market, is preparing for the sale of up to 3,943,334 shares of common stock, which are issuable upon the conversion of certain Senior Secured Convertible Debentures. The sale is set to occur from time to time after the effective date of the registration statement, subject to market conditions. Marpai's common stock was last reported at $0.65 per share on May 29, 2024. The company will not receive any proceeds from the sale of shares by the selling stockholders but will bear the...Show More

Marpai, Inc., a Delaware-based healthcare technology company, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 30, 2024, for a Form S-1 registration. The company, which operates under the ticker symbol MRAI on the OTCQX Market, is preparing for the sale of up to 3,943,334 shares of common stock, which are issuable upon the conversion of certain Senior Secured Convertible Debentures. The sale is set to occur from time to time after the effective date of the registration statement, subject to market conditions. Marpai's common stock was last reported at $0.65 per share on May 29, 2024. The company will not receive any proceeds from the sale of shares by the selling stockholders but will bear the expenses of registering these shares. Marpai has recently transitioned from the Nasdaq Capital Market to the OTCQX Market following non-compliance with Nasdaq's minimum stockholders' equity requirement. The company's comprehensive healthcare programs leverage artificial intelligence and data analytics to support self-insured clients in the U.S. The registration statement includes detailed information about the company, the offering, and the associated risk factors.